Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Lacroix

Showing results (151-160 of 164) with videos related to

Pageof 17
Sort By:
Journal Des Maladies Vasculaires|March 8, 2000
[Teaching targets in vascular medicine]F Becker, H Boccalon, C Boissier, et al.
Behavioural Pharmacology|November 21, 2008
Selective dopamine D4 receptor agonist (A-412997) improves cognitive performance and stimulates motor activity without influencing reward-related behaviour in ratMarie L Woolley, Kerry A Waters, Charlie Reavill, et al.
Psychopharmacology|September 17, 2008
Evaluation of the pro-cognitive effects of the AMPA receptor positive modulator, 5-(1-piperidinylcarbonyl)-2,1,3-benzoxadiazole (CX691), in the ratM L Woolley, K A Waters, J E Gartlon, et al.
Journal Des Maladies Vasculaires|October 7, 2005
[Intermittent claudications]F Becker, J P Boissel, C Boissier, et al.
Psychopharmacology|September 3, 2008
Preclinical investigations into the antipsychotic potential of the novel histamine H3 receptor antagonist GSK207040Eric Southam, Jackie Cilia, Jane E Gartlon, et al.
Journal De Medecine Vasculaire|February 17, 2019
[Unresolved questions on venous thromboembolic disease. Consensus statement of the French Society for Vascular Medicine (SFMV)]I Quéré, A Elias, M Maufus, et al.
Journal De Medecine Vasculaire|June 20, 2019
I Quéré, A Elias, M Maufus, et al.
Journal De Medecine Vasculaire|February 17, 2019
Unresolved questions on venous thromboembolic disease. Consensus statement of the French Society for Vascular Medicine (SFMV)I Quéré, A Elias, M Maufus, et al.
European Journal of Pharmacology|October 31, 2006
SB-399885 is a potent, selective 5-HT6 receptor antagonist with cognitive enhancing properties in aged rat water maze and novel object recognition modelsWarren D Hirst, Tania O Stean, Derek C Rogers, et al.
Neurophysiologie Clinique = Clinical Neurophysiology|November 13, 2007
What is the place of electroneuromyographic studies in the diagnosis and management of pudendal neuralgia related to entrapment syndrome?J-P Lefaucheur, J-J Labat, G Amarenco, et al.
Pageof 17

Showing results (151-160 of 164) with videos related to

Sort By:
Pageof 17
Journal Des Maladies Vasculaires|March 8, 2000
[Teaching targets in vascular medicine]F Becker, H Boccalon, C Boissier, et al.
Behavioural Pharmacology|November 21, 2008
Selective dopamine D4 receptor agonist (A-412997) improves cognitive performance and stimulates motor activity without influencing reward-related behaviour in ratMarie L Woolley, Kerry A Waters, Charlie Reavill, et al.
Psychopharmacology|September 17, 2008
Evaluation of the pro-cognitive effects of the AMPA receptor positive modulator, 5-(1-piperidinylcarbonyl)-2,1,3-benzoxadiazole (CX691), in the ratM L Woolley, K A Waters, J E Gartlon, et al.
Journal Des Maladies Vasculaires|October 7, 2005
[Intermittent claudications]F Becker, J P Boissel, C Boissier, et al.
Psychopharmacology|September 3, 2008
Preclinical investigations into the antipsychotic potential of the novel histamine H3 receptor antagonist GSK207040Eric Southam, Jackie Cilia, Jane E Gartlon, et al.
Journal De Medecine Vasculaire|February 17, 2019
[Unresolved questions on venous thromboembolic disease. Consensus statement of the French Society for Vascular Medicine (SFMV)]I Quéré, A Elias, M Maufus, et al.
Journal De Medecine Vasculaire|June 20, 2019
I Quéré, A Elias, M Maufus, et al.
Journal De Medecine Vasculaire|February 17, 2019
Unresolved questions on venous thromboembolic disease. Consensus statement of the French Society for Vascular Medicine (SFMV)I Quéré, A Elias, M Maufus, et al.
European Journal of Pharmacology|October 31, 2006
SB-399885 is a potent, selective 5-HT6 receptor antagonist with cognitive enhancing properties in aged rat water maze and novel object recognition modelsWarren D Hirst, Tania O Stean, Derek C Rogers, et al.
Neurophysiologie Clinique = Clinical Neurophysiology|November 13, 2007
What is the place of electroneuromyographic studies in the diagnosis and management of pudendal neuralgia related to entrapment syndrome?J-P Lefaucheur, J-J Labat, G Amarenco, et al.
Pageof 17